C3.ai Guides Revenue to $51–55 Million: The "Cheap" AI Stock That Isn't

When C3.ai pointed investors at fiscal Q2 revenue of just $51–55 million, it wasn't issuing a cautious trim. It was describing a company running at roughly half its size of a year earlier, and essentially flat with the quarter it just delivered. The headline number is the story: after a year of steep downward revisions, the enterprise-AI software maker is guiding into a new, lower baseline rather than out of one.

The decline is easy to track because it has been so relentless. In fiscal Q2 2026, ended October 2025, the company still reported $75.1 million in quarterly revenue, with 93% of it subscription-based. By the next quarter it fell to $53.3 million, down 46% year over year, missing the Street's $75.8 million mark by roughly 30%. The most recent reported quarter kept sliding to about $51.6 million, down 52.5% year over year. Guidance for the current quarter of $51–55 million implies revenue is still running about 30% below where it stood a year ago — a year in which the company has repeatedly missed and repeatedly reset expectations.

That cascade matters more than any single number, because it reframes how to read the valuation. C3.ai trades at roughly 6.7 times trailing sales against a roughly $1.7 billion market cap. Beside high-growth software peers — Snowflake at about 21 times sales, Cloudflare near 39 times — that looks like a discount. But a low multiple is only a bargain when the denominator is stable or growing. Here revenue is shrinking by roughly half year over year, gross margin has collapsed to about 31%, and the company is still deeply unprofitable. In the language of the factor stack, this is the load-bearing distinction: C3.ai is not a value name trading cheaply next to quality growth. It is a business whose growth grade is negative and whose profitability grade has deteriorated, and the market's discount to its still-growing peers is the price action correctly repricing that deterioration, not an opportunity the crowd has missed.

The profitability math shows why the low sales multiple is misleading. Trailing twelve-month free cash flow was about negative $192 million, against a reported cash balance near $66 million — a gap that practically guarantees either a capital raise or a severe cost reset before long. Operating margin of roughly negative 200% means the company is spending more than double its revenue every quarter on the way to break-even, and that break-even keeps receding as the revenue base falls out from underneath it. A stock that looks cheap on price-to-sales can still be expensive when the "s" in the equation is disappearing and there is no profit to anchor the other side.

Where does that leave the rating? The honest read is Hold, and nearer the sell side of that band than I buy at. This is not a case of a proven winner whose valuation merely got warm — the classic "hold is not sell" situation. That rule protects companies where growth and revisions stay atop the sector while the multiple runs ahead. C3.ai is the opposite: the eroding report card itself is the signal. Growth turned sharply negative, gross margin broke, and the estimate reset we are watching today is the fourth straight negative revision of real magnitude. That is the dynamic the process tracks, and today it is deteriorating.

For the portfolio, that means no sleeve. In the barbell pairing growth with durable income and safety, C3.ai currently qualifies for neither: not the growth leg, since it is shrinking at double-digit rates while peers grow; not the safety leg, since margin quality is broken and cash burn threatens the balance sheet. It is a name to watch for proof of recovery rather than to buy on a screen. The specific triggers that would change the read are measurable and spelled out in the guidance itself: a quarter where revenue inflects positive and holds above year-ago levels, gross margin recovering toward the 50s, and a credible answer on how the cash lasts. Until those land, the multiple is real but the business underneath it is not yet — and watching a collapsing denominator get "cheaper" is a lesson in why a stock can fall while looking more affordable at every step down.